Company Encyclopedia
View More
name
FOSUN INTL
00656.HK
Fosun International Limited operates in the health, happiness, wealth, and intelligent manufacturing sectors in Mainland China, Portugal, and internationally. It operates through five segments: Health, Happiness, Insurance, Asset Management, and Intelligent Manufacturing. The Health segment engages in the research, development, manufacture, sale, and trading of pharmaceutical and health products; and provision of medical and health management services. The Happiness segment operates and invests in tourism and leisure, fashion consumer, and lifestyle industries.
879.72 B
00656.HKMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
D
Industrial ConglomeratesIndustry
Industry Ranking11/14
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-3.63%D
    • Profit Margin-2.43%D
    • Gross Margin28.14%C
  • Growth ScoreE
    • Revenue YoY-8.60%D
    • Net Profit YoY-696.31%E
    • Total Assets YoY-8.82%E
    • Net Assets YoY-3.93%D
  • Cash ScoreE
    • Cash Flow Margin-4118.26%E
    • OCF YoY-8.60%D
  • Operating ScoreD
    • Turnover0.23D
  • Debt ScoreD
    • Gearing Ratio73.18%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Guo Guangchang: FOSUN will leverage global industrial advantages to promote China's cutting-edge innovation

    FOSUN INTL Chairman Guo Guangchang stated that FOSUN will continue to leverage its global industrial advantages to promote cutting-edge innovation in China. FOSUN showcased innovative drugs and high-end medical devices at the 8th China International Import Expo, focusing on core therapeutic areas such as oncology and immune inflammation. The Import Expo is seen as a window into China's new development pattern, and future innovations in the pharmaceutical and health sectors will target unmet clinical needs

    AASTOCKS·
    HK
    00656
    -1.20%
    SH
    600196
    +0.70%
    HK
    02196
    +0.47%
    AASTOCKS·
    HK
    00656
    -1.20%
    SH
    600196
    +0.70%
    HK
    02196
    +0.47%

    UBS raises FOSUN INTL target price to 5.4 yuan, maintains "Neutral" rating

    UBS raised the target price of FOSUN INTL to HKD 5.4, maintaining a "Neutral" rating. The bank pointed out that FOSUN INTL's stock price has risen about 20% since early April, benefiting from improved sentiment in the mainland and Hong Kong stock markets. Although the stock price has partially reflected the potential for portfolio optimization, attention still needs to be paid to the progress of asset sales and the momentum of the mainland economy

    AASTOCKS·
    HK
    00656
    -1.20%
    AASTOCKS·
    HK
    00656
    -1.20%

    FOSUN INTL subsidiary Fosun High Technology reported a loss of RMB 1.925 billion in the first three quarters

    FOSUN INTL announced that its subsidiary FOSUN High Technology reported a revenue of RMB 67.95 billion for the first three quarters, a year-on-year decrease of 18.6%. The net loss attributable to shareholders was RMB 1.925 billion, compared to a net profit of RMB 351 million in the same period last year, turning from profit to loss

    AASTOCKS·
    HK
    00656
    -1.20%
    AASTOCKS·
    HK
    00656
    -1.20%

    FOSUN INTL: FOSUN High Technology's operating income for the first three quarters is approximately 67.95 billion yuan

    According to the Zhitong Finance APP, FOSUN INTL announced that its subsidiary Shanghai Fosun High Technology (Group) Co., Ltd. (Fosun High Technology) achieved an operating income of approximately 67.95 billion yuan for the nine months ending September 30, 2025

    Zhitong·
    HK
    00656
    -1.20%
    Zhitong·
    HK
    00656
    -1.20%

    The new residential site at Tai Wai approved for a 30-story residential building by New World Development

    New World Development has been approved to build a 30-story residential building on Mei Tin Road in Tai Wai, along with two levels of basement, with a total floor area of approximately 193,800 square feet. The project was acquired for HKD 606 million in January this year. The Buildings Department approved a total of 6 building plans in August, including three residential and mixed-use developments, two commercial developments, and one community service development. In addition, FOSUN INTL's Sai Kung Clearwater Bay project has been approved for significant revisions, reducing the number of residential buildings from 23 to 17

    AASTOCKS·
    HK
    00656
    -1.20%
    AASTOCKS·
    HK
    00656
    -1.20%
    © 2025 Longbridge｜Disclaimer